TAMAR GERMAN
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant SALISBURY, MD NPI 1922465541
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant MD ABBVIE INC. All categories
General Payments — all program years on this page
$1,962.07
- Category: General Payments
- Program years: PY2021–2022
- Record count: 122
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $967.01 across 54 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $967.01 | 54 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $238.58 | 16 |
| GlaxoSmithKline, LLC. | $111.12 | 5 |
| Amgen Inc. | $71.22 | 4 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $66.72 | 3 |
| Kowa Pharmaceuticals America, Inc. | $59.08 | 3 |
| Lilly USA, LLC | $48.86 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $39.00 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $37.16 | 2 |
| ATRICURE, INC. | $37.06 | 1 |
| Acerta Pharma LLC | $34.43 | 2 |
| Janssen Pharmaceuticals, Inc | $33.97 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.72 | 2 |
| PFIZER INC. | $32.88 | 2 |
| Amarin Pharma Inc. | $24.11 | 1 |
| Esperion Therapeutics, Inc. | $23.36 | 1 |
| Xeris Pharmaceuticals, Inc. | $18.67 | 1 |
| Horizon Pharma plc | $17.87 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $14.77 | 1 |
| Merck Sharp & Dohme Corporation | $12.55 | 1 |
| Novo Nordisk AS | $11.88 | 1 |
By program year
Records — PY2022 (54)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.